Ekso Bionics Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Segment Disclosures (Tables)

Segment Disclosures (Tables)

12 Months Ended

Dec. 31, 2014

Schedule of Segment Reporting Information

Segment reporting information is as follows:

	Engineering		Medical
	Services		Devices		Total
Year ended December 31, 2014
Revenue	$	2,403	$	2,924	$	5,327
Cost of revenue		1,720		2,048		3,768
Gross profit	$	683	$	876	$	1,559

Year ended December 31, 2013
Revenue	$	1,690		1,612	$	3,302
Cost of revenue		1,254		1,461		2,715
Gross profit	$	436	$	151	$	587

Year ended December 31, 2012
Revenue	$	2,140	$	566	$	2,706
Cost of revenue		1,783		553		2,336
Gross profit	$	357	$	13	$	370

Schedule of Geographic Information

Geographic information based on location of customer is as follows:

	Years Ended December 31,
	2014		2013		2012
North America	$	4,214	$	2,847	$	2,706
All Other		1,113		455		–
	$	5,327	$	3,302	$	2,706

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details